报价延迟最少15分钟:2026/05/20 02:44 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.51 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-7.47/-25.88
|
|
企业价值
1.29M
|
| 资产负债 |
|
每股账面净值
10.12
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
17.00K
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings. |
